(Q27888072)
Statements
C₂₁H₂₄ClN₇O₂S
1 reference
Pazopanib hydrochloride (English)
19 November 2016
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl
1 reference
Pazopanib hydrochloride (English)
19 November 2016
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
Identifiers
1 reference
Pazopanib hydrochloride (English)
19 November 2016
2 references
Pazopanib hydrochloride (English)
19 November 2016
2 references
pazopanib hydrochloride (English)
19 November 2016
1 reference
Pazopanib Hydrochloride (English)
19 November 2016
2 references
Pazopanib hydrochloride (English)
19 November 2016
2 references
PAZOPANIB HYDROCHLORIDE (English)
19 November 2016
1 reference
PAZOPANIB HYDROCHLORIDE (English)
19 November 2016
619-728-0
1 reference
27 December 2018
5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride (English)
CAS no.: 635702-64-6 (English)
1 reference
27 December 2018
5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide hydrochloride (English)
CAS no.: 635702-64-6 (English)
1 reference
pazopanib hydrochloride (English)
19 November 2016
2 references
pazopanib hydrochloride (English)
19 November 2016